These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 30348199)

  • 1. Tumor-derived granulocyte colony-stimulating factor diminishes efficacy of breast tumor cell vaccines.
    Ravindranathan S; Nguyen KG; Kurtz SL; Frazier HN; Smith SG; Koppolu BP; Rajaram N; Zaharoff DA
    Breast Cancer Res; 2018 Oct; 20(1):126. PubMed ID: 30348199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xuanhusuo powder has an anti-breast cancer effect by inhibiting myeloid-derived suppressor cell differentiation in the spleen of mice through down-regulating granulocyte colony stimulating factor.
    Mao Y; Liu X; He K; Lin C; He B; Gao J
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Feb; 52(1):88-100. PubMed ID: 37283122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a highly immunogenic mouse breast cancer sub cell line, 4T1-S.
    Abe H; Wada H; Baghdadi M; Nakanishi S; Usui Y; Tsuchikawa T; Shichinohe T; Hirano S; Seino K
    Hum Cell; 2016 Apr; 29(2):58-66. PubMed ID: 26857856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination of women with metastatic breast cancer, using a costimulatory gene (CD80)-modified, HLA-A2-matched, allogeneic, breast cancer cell line: clinical and immunological results.
    Dols A; Smith JW; Meijer SL; Fox BA; Hu HM; Walker E; Rosenheim S; Moudgil T; Doran T; Wood W; Seligman M; Alvord WG; Schoof D; Urba WJ
    Hum Gene Ther; 2003 Jul; 14(11):1117-23. PubMed ID: 12885350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice.
    Jadidi-Niaragh F; Atyabi F; Rastegari A; Kheshtchin N; Arab S; Hassannia H; Ajami M; Mirsanei Z; Habibi S; Masoumi F; Noorbakhsh F; Shokri F; Hadjati J
    J Control Release; 2017 Jan; 246():46-59. PubMed ID: 27993599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
    da Cunha A; Antoniazi Michelin M; Cândido Murta EF
    Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status of autologous breast tumor cell-based vaccines.
    Kurtz SL; Ravindranathan S; Zaharoff DA
    Expert Rev Vaccines; 2014 Dec; 13(12):1439-45. PubMed ID: 25308888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer Cell-Derived Granulocyte-Macrophage Colony-Stimulating Factor Is Dispensable for the Progression of 4T1 Murine Breast Cancer.
    Yoshimura T; Nakamura K; Li C; Fujisawa M; Shiina T; Imamura M; Li T; Mukaida N; Matsukawa A
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31888216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination with leukemia cells expressing cell-surface-associated GM-CSF blocks leukemia induction in immunocompetent mice.
    Ling X; Wang Y; Dietrich MF; Andreeff M; Arlinghaus RB
    Oncogene; 2006 Jul; 25(32):4483-90. PubMed ID: 16547503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting myeloid-derived suppressor cells in combination with primary mammary tumor resection reduces metastatic growth in the lungs.
    Bosiljcic M; Cederberg RA; Hamilton MJ; LePard NE; Harbourne BT; Collier JL; Halvorsen EC; Shi R; Franks SE; Kim AY; Banáth JP; Hamer M; Rossi FM; Bennewith KL
    Breast Cancer Res; 2019 Sep; 21(1):103. PubMed ID: 31488209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of a novel vaccine approach using tumor cells that ectopically express a codon-optimized murine GM-CSF in a murine tumor model.
    Lin CC; Tsai CC; Lee JM; Fang CH; Chang KS; Wong KK; Lin CT; Qiu JT
    Vaccine; 2016 Jan; 34(1):134-41. PubMed ID: 26546261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing the potency of a whole-cell breast cancer vaccine in mice with an antibody-IL-2 immunocytokine that targets exposed phosphatidylserine.
    Huang X; Ye D; Thorpe PE
    Vaccine; 2011 Jun; 29(29-30):4785-93. PubMed ID: 21557977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EphA4-deleted microenvironment regulates cancer development and leukemoid reaction of the isografted 4T1 murine breast cancer via reduction of an IGF1 signal.
    Jing X; Sonoki T; Miyajima M; Sawada T; Terada N; Takemura S; Sakaguchi K
    Cancer Med; 2016 Jun; 5(6):1214-27. PubMed ID: 26923183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of tumor vaccine expressing Granulocyte-Macrophage Colony Stimulating Factor and interleukin-18 fusion on cancer cells and its possible application for cancer immunotherapy.
    Lee SR; Park YK; Shin BA; Park HR
    Cytokine; 2017 Jan; 89():143-154. PubMed ID: 26868088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced tumor protection by granulocyte-macrophage colony-stimulating factor expression at the site of an allogeneic vaccine.
    Thomas MC; Greten TF; Pardoll DM; Jaffee EM
    Hum Gene Ther; 1998 Apr; 9(6):835-43. PubMed ID: 9581906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. rWTC-MBTA: autologous vaccine prevents metastases via antitumor immune responses.
    Ye J; Wang H; Medina R; Chakraborty S; Sun M; Valenzuela A; Sang X; Zhang Y; Uher O; Zenka J; Pacak K; Zhuang Z
    J Exp Clin Cancer Res; 2023 Jul; 42(1):163. PubMed ID: 37434263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fully synthetic glycopeptide MAG-Tn3 therapeutic vaccine induces tumor-specific cytotoxic antibodies in breast cancer patients.
    Rosenbaum P; Artaud C; Bay S; Ganneau C; Campone M; Delaloge S; Gourmelon C; Loirat D; Medioni J; Pein F; Sablin MP; Tredan O; Varga A; Leclerc C
    Cancer Immunol Immunother; 2020 May; 69(5):703-716. PubMed ID: 32034426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic vaccination based on side population cells transduced by the granulocyte-macrophage colony-stimulating factor gene elicits potent antitumor immunity.
    Sakamoto C; Kohara H; Inoue H; Narusawa M; Ogawa Y; Hirose-Yotsuya L; Miyamoto S; Matsumura Y; Yamada K; Takahashi A; Tani K
    Cancer Gene Ther; 2017 Apr; 24(4):165-174. PubMed ID: 28084317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A GM-CSF and CD40L bystander vaccine is effective in a murine breast cancer model.
    Soliman H; Mediavilla-Varela M; Antonia SJ
    Breast Cancer (Dove Med Press); 2015; 7():389-97. PubMed ID: 26719725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SV-BR-1-GM, a Clinically Effective GM-CSF-Secreting Breast Cancer Cell Line, Expresses an Immune Signature and Directly Activates CD4
    Lacher MD; Bauer G; Fury B; Graeve S; Fledderman EL; Petrie TD; Coleal-Bergum DP; Hackett T; Perotti NH; Kong YY; Kwok WW; Wagner JP; Wiseman CL; Williams WV
    Front Immunol; 2018; 9():776. PubMed ID: 29867922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.